Business

ZLD secures US$8.6 million funding for HOPE 1 US FDA trials

ZLD secures US$8.6 million funding for HOPE 1 US FDA trials

Zelira Therapeutics Ltd.February 14, 20234
ZLD secures US$8.6 million funding for HOPE 1 US FDA trials

About this update from Zelira Therapeutics Ltd.

Zelira Therapeutics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Zelira Therapeutics Ltd.

More from Zelira Therapeutics Ltd.

All Zelira Therapeutics Ltd. news →